The pathogenesis of human acute ischemic renal failure is complex. Studies in animals have revealed a number of factors that could contribute to the injury associated with acute ischemic renal failure. Despite these discoveries, we have yet to devise a therapeutic regimen that will ameliorate or prevent acute renal failure in humans. Nevertheless we have made great strides in understanding mechanisms that contribute to acute ischemic renal failure. An important component is the contribution of the inflammatory cascade brought about by tissue reperfusion following an ischemic period. This review summarizes recent studies that implicate the inflammatory cells in the development of renal injury associated with acute ischemic renal failure. Because of the complex overlapping pathways involved in the inflammatory cascade, blocking single molecules is unlikely to be successful in reducing renal injury. Rather broadly abrogating the inflammatory cascade is likely to yield the greatest success in the treatment and prevention of acute ischemic renal failure.

1.
Levy EM, Viscoli CM, Horwitz RI: The effect of acute renal failure on mortality. A cohort analysis. JAMA 1996;275:1489–1494.
2.
Star RA: Treatment of acute renal failure. Kidney Int 1998;54:1817–1831.
3.
Kelly KJ, Molitoris BA: Acute renal failure in the new millennium: Time to consider combination therapy. Sem Nephrol 2000;20:4–19.
4.
Thadhani R, Pascual M, Bonventre JV: Acute renal failure. N Engl J Med 1996;334:1448–1460.
5.
Edelstein CL, Ling H, Schrier RW: The nature of renal cell injury. Kidney Int 1997;51:1341–1351.
6.
Brezis M, Rosen SN, Epstein FH: The pathophysiological implications of medullary hypoxia. Am J Kid Dis 1989;13:253–258.
7.
Spielman WS, Arend LJ: Adenosine receptors and signaling in the kidney. Hypertension 1991;17:117–130.
8.
Weinberg JM: The cell biology of ischemic renal injury. Kidney Int 1991;39:476–500.
9.
Nath KA, Norby SM: Reactive oxygen species and acute renal failure. Am J Med 2000;109:655–678.
10.
Klausner JM, Paterson IS, Goldman G, Kobzik L, Rodzen C, Lawrence R, Valeri CR, Shepro D, Hechtman HB: Postischemic renal injury is mediated by neutrophils and leukotrienes. Am J Physiol 1989;256:F794–F802.
11.
Heinzelmann M, Mercer-Jones MA, Passmore JC: Neutrophils and renal failure. Am J Kid Dis 1999;34:384–399.
12.
Yu L, Gengaro PE, Niederberger M, Burke TJ, Schrier RW: Nitric oxide: A mediator in rat tubular hypoxia/reoxygenation injury. Proc Natl Acad Sci 1994;91:1691–1695.
13.
Peresleni T, Noiri E, Bahou WF: Antisense oligodeoxynucleotides to inducible NO synthase rescue epithelial cells from oxidative stress injury. Am J Physiol 1996;270:F971–F977.
14.
Noiri E, Peresleni T, Miller F, Goligorsky MS: In vivo targeting of inducible NO synthase with oligodeoxynucleotides protects rat kidneys against ischemia. J Clin Invest 1996;97:2377–2383.
15.
Ling H, Edelstein C, Gengaro P, Meng X, Lucia S, Knotek M, Wangsiripaisan A, Shi Y, Schrier R: Attenuation of renal ischemia-reperfusion injury in inducible nitric oxide synthase knockout mice. Am J Physiol 1999;277:F383–F390.
16.
Kone BC: Nitric oxide in renal health and disease. Am J Kid Dis 1997;30:311–333.
17.
Paller MS: Effect of neutrophil depletion on ischemic renal injury in the rat. J Lab Clin Med 1989;113:379–386.
18.
Caramelo C, Arroyo MVA: Polymorphoneutrophils in acute renal failure: New insights. Nephrol Dial Transplant 1998;13:2185–2188.
19.
Willinger CC, Schramek H, Pfaller K, Pfaller W: Tissue distribution of neutrophils in postischemic acute renal failure. Virchows Arch[B] 1992;62:237–243.
20.
Chiao H, Kohda Y, McLeroy P, Craig L, Housini I, Star RA: α-Melanocyte-stimulating hormone protects against renal injury after ischemia in mice and rats. J Clin Invest 1997;99:1165–1172.
21.
Linas S, Whittenburg D, Repine JE: Nitric oxide prevents neutrophil-mediated acute renal failure. Am J Physiol 1996;272:F48–F54.
22.
Rabb H, O’Meara YM, Maderna P, Coleman P, Brady H: Leukocytes, cell adhesion molecules and ischemic acute renal failure. Kidney Int 1997;51:1463–1468.
23.
Okusa MD, Linden J, Huang L, Rieger JM, Macdonald TL, Huynh LP: A2a-Adenosine receptor-mediated inhibition of renal injury and neutrophil adhesion. Am J Physiol 2000;279:F809–F818.
24.
Linas SL, Whittenburg D, Parsons PE, Repine JE: Mild renal ischemia activates primed neutrophils to cause acute renal failure. Kidney Int 1992;42:610–616.
25.
Bradley PP, Priebat DA, Christensen RD, Rothstein G: Measurement of cutaneous inflammation: Estimation of neutrophil content with enzyme marker. J Invest Dermatol 1982;78:206–209.
26.
Thornton MA, Winn R, Alpers E, Zager RA: An evaluation of the neutrophil as a mediator of in vivo renal ischemic-reperfusion injury. Am J Pathol 1989;135:509–515.
27.
Kelly KJ, Williams WW, Colvin RB, Bonventre JV: Antibody to intercellular adhesion molecule 1 protects the kidney against ischemic injury. Proc Natl Acad Sci 1994;91:812–816.
28.
Rabb H, Mendiola CC, Saba SR, Dietz JR, Smith CW, Bonventre JV, Ramirez G: Antibodies to ICAM-1 protect kidneys in severe ischemic reperfusion injury. Biochem Biophys Res Commun 1995;211:67–73.
29.
Haller H, Dragun D, Miethke A, Park JK, Weis A, Lippoldt A, Grob V, Luft FC: Antisense oligonucleotides for ICAM-1 attenuate reperfusion injury and renal failure in the rat. Kidney Int 1996;50:473–480.
30.
Dragon D, Tullius SG, Park JK, Maasch C, Lukitsch I, Lippoldt A, Grob V, Luft FC, Haller H: ICAM-1 antisense oliogodesoxynucleotides prevent reperfusion injury and enhance immediate graft function in renal transplantation. Kidney Int 1998;54:590–602.
31.
Kelly KJ, Williams WW, Colvin RB, Meehan SM, Springer TA, Gutierrez-Ramos J, Bonventre JV: Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. J Clin Invest 1996;97:1056–1063.
32.
Chiao H, Kohda Y, McLeroy P, Craig L, Linas S, Star RA: A melanocyte-stimulating hormone inhibits renal injury in the absence of neutrophils. Kidney Int 1998;54:765–774.
33.
Singbartl K, Green SA, Ley K: Blocking P-selectin protects from ischemia/reperfusion-induced acute renal failure. FASEB J 2000;14:48–54.
34.
Singbartl K, Ley K: Protection from ischemia-reperfusion induced severe acute renal failure by blocking E-selectin. Crit Care Med 2000;28:2507–2514.
35.
Okusa MD, Linden J, Huang L, Rosin DL, Smith DF, Sullivan G: Enhanced protection from renal ischemia-reperfusion injury with A2A-adenosine receptor activation and PDE 4 inhibition. Kidney Int 2001;59:2114–2125.
36.
Solez K, Morel-Maroger L, Sraer JD: The morphology of ‘acute tubular necrosis’ in man: Analysis of 57 renal biopsies and a comparison with the glycerol model. Medicine (Baltimore) 1979;58:362–376.
37.
Takada M, Nadeau KC, Shaw GD, Maruette KA, Tilney NL: The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. J Clin Invest 1997;99:2682–2690.
38.
Rabb H, Daniels F, O’Donnell M, Haq M, Saba SR, Keane W, Tang WW: Pathophysiological role of T lymphocytes in renal ischemia-reperfusion injury. Am J Physiol 2000;279:F525–F531.
39.
Frangogiannis NG, Youker KA, Rossen RD, Gwechenberger M, Lindsey MH, Mendoza LH, Michael LH, Ballantyne CM, Smith CW, Entman ML: Cytokines and the microcirculation in ischemia and reperfusion. J Mol Cell Cardiol 1998;30:2567–2576.
40.
Kubes P, Granger DN: Leukocyte-endothelial cell interactions evoked by mast cells. Cardiovasc Res 1996;32:699–708.
41.
Johnston B, Kubes P: Mast cells in inflammation: Physiology of Inflammation. Oxford, University Press, 2001 pp 473–495.
42.
Vodenicharov A, Chouchkov C: Morphological study of mast cell localization in the wall of the proximal tubule in the domestic swine kidney. Anat Histol Embryol 1999;28:85–88.
43.
Granger DN: Cell adhesion and migration II. Leukocyte-endothelial cell adhesion in the digestive system. Am J Physiol 1997;273:G982–G986.
44.
Okusa MD, Linden J, Huang L, Seaner R, Obrig T: Attenuation of renal inflammation by A2A-adenosine receptor (A2A-AR) activation in ischemia-reperfusion injury (I/R): Regulation of cytokine and adhesion molecule expression. J Am Soc Nephrol 2000;11:132A.
45.
Lakshminarayanan V, Beno DWA, Costa RH, Roebuck KA: Differential regulation of interleukin-8 and intercellular adhesion molecule-1 by H2O2 and tumor necrosis factor-α in endothelial and epithelial cells. J Biol Chem 1997;272:32910–32918.
46.
Mulligan M, Vaporciyan AA, Miyasaka M, Tamatani T, Ward PA: Tumor necrosis factor-α regulates in vivo intrapulmonary expression of ICAM-1. Am J Pathol 1993;142:1739–1749.
47.
Carden DL, Granger DN: Pathophysiology of ischaemia-reperfusion injury. J Pathol 2000;190:255–266.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.